Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) Revolutionary Process Creates Superior Cannabinoid Edibles
Disruptive, patented technology is set to revolutionize the edible cannabis market Company has patent applications in 45 countries, including 18 applications in the U.S. Technology is patent-protected for CBD and all other non-psychoactive cannabinoids, with patents pending for THC, other psychoactive cannabinoids, NSAIDs, nicotine and other molecules A common complaint among the consumers of cannabis edibles is an unpleasant taste that can often be detected, but that unpleasant taste and other inadequacies of cannabis edibles are being overcome thanks to the incredible innovations of Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP). Lexaria is literally bringing new flavor to the marijuana…







